The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells.
Dong J, Park SY, Nguyen N, Ezhilarasan R, Martinez-Ledesma E, Wu S, Henry V, Piao Y, Tiao N, Brunell D, Stephan C, Verhaak R, Sulman E, Balasubramaniyan V, de Groot JF.
Dong J, et al. Among authors: tiao n.
Oncotarget. 2018 Jan 8;9(12):10497-10509. doi: 10.18632/oncotarget.24041. eCollection 2018 Feb 13.
Oncotarget. 2018.
PMID: 29535822
Free PMC article.